Application of N6022 in prevention and treatment of aortic dissection and aortic aneurysm
A technology for aortic dissection and aortic aneurysm, applied in the direction of medical preparations containing active ingredients, cardiovascular system diseases, organic active ingredients, etc., to reduce the occurrence of hematoma, reduce excessive collagen deposition on the vessel wall, and maintain integrity Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Example 1: Inhibitory effect of N6022 on occurrence and rupture of aortic dissection
[0020] In order to explore the effect of N6022 on the occurrence and rupture of aortic dissection, we selected SPF grade 4-week-old C57BL / 6 mice (purchased from the Medical Experimental Animal Center of Nanjing Medical University) and randomly divided them into five groups: solvent control group (Control+ DMSO), aortic dissection model solvent control group (BAPN+DMSO) and three different N6022 concentrations (0.01mg / kg / day, 0.1mg / kg / day, 1mg / kg / day) aortic dissection model administration groups. Wherein the model of aortic dissection is when the mice were 4 weeks old, by infiltrating β-aminopropionitrile (BAPN) 1g / kg / day in the drinking water, and injecting different concentrations of N6022 (0.01mg / kg / day, 0.1mg / kg / day, 1mg / kg / day), the survival of the mice was observed every 5 days, and after 4 weeks, the aorta of the mice was isolated, and the incidence rate and rupture rate of ao...
Embodiment 2
[0023] Example 2: Inhibitory effect of N6022 on formation and rupture of aortic aneurysm
[0024] In order to explore the effect of N6022 on tumor formation and rupture in aortic aneurysm model mice, we selected SPF grade 8-week-old male ApoE - / - Mice (purchased from Nanjing Junke Bioengineering Co., Ltd.) were randomly divided into three groups: solvent control group (Saline+DMSO), aortic aneurysm model solvent control group (AngII+DMSO) and aortic aneurysm model administration group ( AngII+N6022). That is, when the mice were 8 weeks old, an osmotic micropump (Alzet, USA, 2004 model) was implanted subcutaneously through the back, the control group was given normal saline, the aortic aneurysm model solvent control group and the aortic aneurysm model administration group were given Ang II ( 1000ng / kg / min), and the control solvent DMSO or N6022 (0.1mg / kg / day) was injected into the tail vein. The mortality rate of mice was observed every 5 days, and the formation of aortic ane...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com